Endonovo's tPEMF products provide a solution that will improve patient outcomes and provide operational and financial benefits to the healthcare providers. SofPulse facilitates the natural recovery process with improved outcomes and reduced cost.​

A survey conducted by the American Hospital Association reports that seven out of
10 hospitals have seen a decline in their financial health over recent years. Demand
and hospital expense is increasing but reimbursement is declining and there are fewer
donations/investments being made. In order for a hospital to maintain viability, they must
focus on improving patient care while reducing operating expenses.


Management of pain is a central issue in the delivery of high quality patient care.
Intravenous patient-controlled analgesia (IV PCA) with opioids is common; however
it carries significant risks and costs. The cost of IV PCA errors was $388 million in 2004
(Meissner, Nelson & Hicks, 2009).


A product that allows for accelerated post-surgical recovery and a decrease in post-op pain and narcotic use may reduce the risk of these IV PCA errors and may also reduce hospital length of stay and save the hospital an average of $1,000/day.
(Taheri et al, 2000; Rothbert et al, 2005; Whelan, 2010)

Other areas of savings include:


  • Decreases costs associated with wound care - 60% reduction (Luu, et al, 2008)

  • Decreased NPWT costs $150,000 annually and accelerated wound healing 33% over four years, 2000 patients (Hall, 2006)

  • Accelerates discharges in post-surgical patients: decreased post-surgical hospitalizations by 1-3 days (Strauch, et al, 2009)

  • Reduces post-op pain (57%+) and narcotic use (2.2 fold), reduced wound exudate 275% (Rhode, et al, 2009)

  • Could potentially lead to lower morbidity, enhanced surgical healing, shorter hospital stays, increased productivity, and a reduction in the cost of health care. (Rhode, et al, 2015)


Endonovo Therapeutics logo

Contact Us:

Copyright 2018-2019 Endonovo Therapeutics, Inc.
All Rights Reserved | Sitemap |

  • Facebook Social Icon
  • Twitter Social Icon
  • YouTube Social  Icon

The information included in this web site has been prepared for and is intended for viewing by residents of the United States of America. This web site contains information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us regarding the purchase or sale of SofPulse in other countries.